X

Gufic BioSciences Ltd Q1FY24; 18% rise in Revenue

Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.


Financial Results:

  • Gufic BioSciences Ltd reported Revenues for Q1FY24 of ₹195.00 Crores up from ₹165.00 Crore year on year, a rise of 18.18%.
  • Total Expenses for Q1FY24 of ₹168.00 Crores up from ₹137.00 Crores year on year, a rise of 22.63%.
  • Consolidated Net Profit of ₹21.00 Crores from ₹21.00 Crores in the same quarter of the previous year.
  • The Earnings per Share is ₹2.13, down 1.84% from ₹2.17 in the same quarter of the previous year.
Related Post